Headline–confidence gap
Headline confirmed
Management confidence reinforces the reported beat.
TMO delivered strong 10% revenue growth and 13% adjusted EPS growth, demonstrating strengthening end markets.
Management confidence reinforces the reported beat.
We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellent execution and the power of our PPI Business System.
“We delivered outstanding performance in the second quarter, reflecting the strength of our proven growth strategy, our team’s excellent execution and the power of our PPI Business System.”
“Our end markets continue to strengthen and we're making great progress enhancing our capabilities, and further advancing our trusted partner status with customers, leading to continued share gain.”
“At the halfway point of the year, we are well positioned to deliver a great 2026 and build an even brighter future for our company.”
The company stated it would provide updated 2026 financial guidance during its earnings conference call.
0 potential deflections detected in management communication.
Announced the divestiture of the microbiology business and repurchased $1.0 billion of stock during the quarter.
No material Q&A deflections were detected.